MAGL inhibitors (Lunan Pharmaceutical Group)

N/A

Report date: 2025/03/20 15:47:20
NME

Base Information

Drug NameMAGL inhibitors (Lunan Pharmaceutical Group)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoglyceride lipase inhibitors
TargetsMonoglyceride lipase
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLunan Pharmaceutical Group Co
China Registration ClassN/A

Develop Information

Active CompaniesLunan Pharmaceutical Group Co
Inactive CompaniesN/A
Active IndicationsDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A